TNF and neoplasm: This subtype also showed the strongest TNF-α–CA19-9 correlation (rho ≈ 0.79) in a subset analysis, suggesting intestinal-type cancers might drive a particularly robust inflammatory (TNF-α) and tumor marker (CA19-9) response.